http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-155098-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c275038cf36535d44a526cb28203c03d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D453-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-32
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-22
filingDate 1981-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41e9ec692ed2e25c4a886ffd92a685d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3d8ad1bc570a7c4264d7898cb5860bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d81e639c09c458ee13253a89b008bbf
publicationDate 1986-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-155098-B
titleOfInvention ANALOGUE PROCEDURE FOR THE PREPARATION OF PHARMASOYTIC ACTIVE AZA-BICYCLO-OCTANE CARBOXYL ACIDS.
abstract Compounds of formula. wherein A represents a vinylene or dimethylene residue, q is 0 or 1, R is an alkyl residue which may have an amino group, X represents -S- or -NH-, and R is a hydrogen atom or a residue of the formula. wherein Pure hydroxy or alkoxy, and R 1 is a hydrogen atom or an alkyl, cycloalkylalkyl or phenylalkyl radical each having not more than a total of 8 carbon atoms, or an unsubstituted or substituted alkylthioalkyl radical. The preparation of the compounds is described. have therapeutic activity, especially antihypertensive activity.
priorityDate 1980-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 33.